Home » Topics » Medical technology

Medical technology
RSS

Galapagos Enters New RA Alliance With Janssen

Oct. 31, 2007

By Peter O'Donnell

AstraZeneca Folds Cambridge Antibody Into MedImmune

Oct. 31, 2007

By Jennifer Boggs

Europe Still Undecided In Prolonged GM Debate

Oct. 31, 2007

By Peter O'Donnell

Clinic Roundup

Oct. 31, 2007

U.S. Patent Disclosures

Oct. 31, 2007

Other News To Note

Oct. 31, 2007

Neurobiological Offering Nets $56 Million For Viprinex Trials

Oct. 31, 2007

By Trista Morrison

Ipsat Reports Positive Phase IIb Data For P1A

Oct. 31, 2007

By Cormac Sheridan

Genetic Discovery Could Speed Help For Ankylosing Spondylitis

Oct. 31, 2007

By Sharon Kingman

Oxford Immunotec Raises $40M For U.S. TB Test Launch

Oct. 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.